March 17, 2026

Recursion Pharmaceuticals (RXRX) Stock Analysis: Navigating a 98% Potential Upside in the Biotech Arena

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is garnering significant attention in the biotechnology sector, particularly due to its impressive 98.06% potential upside as indicated by analyst target price ranges. As a..

Adaptive Biotechnologies Corpor (ADPT) Stock Analysis: A 56% Upside Potential Amid Strong Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its promising 56.59% potential upside. As a commercial-stage company headquartered in..

Vericel Corporation (VCEL) Stock Analysis: A 71.66% Potential Upside in Biotech

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 71.66%, according to analyst consensus. Headquartered in Cambridge, Massachusetts, Vericel..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 50% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS) has emerged as a noteworthy player within the healthcare sector, specifically in the medical instruments and supplies industry. Based in Kirkland, Washington, the company specializes..

Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 64.5% Potential Upside in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is gaining attention from investors due to its promising pipeline aimed at addressing serious hematologic diseases. With a robust market capitalization..

Clover Health Investments (CLOV): Evaluating the 51% Potential Upside for Investors

Clover Health Investments, Corp (NASDAQ: CLOV), a player in the healthcare plans sector, is grabbing attention with its significant potential upside of 51.44%. This enticing figure has prompted investors to..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unlocking a Potential 52% Upside in Biotech Innovation

Travere Therapeutics, Inc. (NASDAQ: TVTX), a prominent player in the biotechnology sector, is capturing investor attention with its innovative therapeutic solutions targeting rare kidney and metabolic diseases. With a robust..

Azenta, Inc. (AZTA) Investor Outlook: Positioned for an 84.92% Upside with Promising Analyst Ratings

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector’s medical instruments and supplies industry, offers a unique investment opportunity with a notable potential upside of 84.92%. As the..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Potential 48.91% Upside with Strong Buy Ratings

Investors looking for opportunities in the biotech sector may want to keep a close eye on Apogee Therapeutics, Inc. (NASDAQ: APGE). Based in Waltham, Massachusetts, this clinical-stage biotechnology company is..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Potential Upside of 97% Beckons Investors

Investors with an eye on the biotechnology sector may want to take a closer look at Vera Therapeutics, Inc. (NASDAQ: VERA), a promising player in the healthcare industry focused on..

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking a Potential 128.86% Upside in Biotech

Biohaven Ltd. (BHVN), a burgeoning player in the biotechnology sector, is gaining substantial attention from investors due to its ambitious pipeline and significant potential upside. With a market capitalization of..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 92% Potential Upside in the Biotech Sector

Structure Therapeutics Inc. (GPCR) presents a compelling opportunity for investors in the biotechnology sector, with recent analyst ratings suggesting a substantial potential upside of 92.29%. The company, headquartered in South..

Pediatrix Medical Group (MD) Stock Analysis: Evaluating a 9.46% Potential Upside in the Healthcare Sector

Pediatrix Medical Group, Inc. (NYSE: MD) stands out in the healthcare sector with its specialized focus on providing neonatal and maternal-fetal medical care. As a key player in the medical..

Dynavax Technologies Corporation (DVAX): Investor Outlook on Potential Upside and Revenue Growth

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. As a commercial-stage biopharmaceutical company, Dynavax is well-positioned to..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 72.94% Potential Upside Amidst Groundbreaking Gene Editing Innovations

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology revolution with its pioneering work in gene editing. This Swiss-based company, operating within the healthcare sector, leverages its..

Omnicell, Inc. (OMCL) Stock Analysis: A 67% Upside Potential Amid Healthcare Technology Innovation

Omnicell, Inc. (OMCL), a prominent player in the healthcare technology sector, is capturing investor attention with its robust growth potential. With a market capitalization of $1.56 billion, Omnicell is well-positioned..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring the 62.20% Potential Upside

For investors seeking opportunities in the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) presents a fascinating prospect with its significant potential upside of 62.20%. Specializing in innovative medical devices for the..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Why Analysts Are Bullish with a 37% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) is gaining significant attention in the biotechnology sector for its promising pipeline of treatments targeting rare neuromuscular diseases. With a market capitalization of $4.63..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Biotech Powerhouse in Rare Diseases with Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is capturing the attention of the healthcare investment community with its strategic focus on rare diseases. Headquartered in Princeton, New Jersey, this biotechnology firm is..

GeneDx Holdings Corp. (WGS) Investor Outlook: Potential 105.84% Upside Amid Strong Buy Ratings

GeneDx Holdings Corp. (NASDAQ: WGS) is making waves in the healthcare sector with its innovative approach to genetic testing services. The company, headquartered in Stamford, Connecticut, is at the forefront..

Search

Funds

March 17, 2026

Search

Funds

March 17, 2026

FTSE 100

Funds